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Abstract-In a previous tudy it was shown that antibody formation after vaccination with a low-dose 
recombinant DNA (rDNA) hepatitis B vaccine was negatively influenced by psychological stress. The 
present study was designed toassess whether the same inverse relation between HBs-antibody levels and 
psychological stress could be observed, while administering the standard, and thus higher, dose of vaccine. 
Volunteers (n = 68) scoring extremely ow or high on a combination of questionnaires measuring daily 
problems and psychoneurotic symptoms were selected for participation. Antibody levels were determined 
2, 6, and 7 months after the first vaccination. Questionnaires were completed before entering the study 
and at month 6. In contrast to the previous tudy, psychological stress was not found to be related to the 
antibody levels at any timepoint. These results uggest that, under certain conditions, stress-induced 
immunomodulation n vivo might be dependent on antigen dose. 
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INTRODUCTION 
Nowadays it is well established that psychological factors can influence immune 
functioning. Until now research in psychoneuroimmunology (PNI) has largely focused 
on in vitro immune parameters. However, such in vitro parameters do not always 
have unequivocal relevance in terms of clinical practice. In vivo immune reactivity, 
(e.g., after an immunizat ion or antigenic hallenge) can yield more relevant informa- 
tion in this respect. Cohen and Wil l iamson [1] have emphasized the need for prospec- 
tive infectious-challenge studies to evaluate the role of psychological stress in disease 
susceptibility and course of clinical manifestations. Prospective studies allow the 
experimenter to control for variables like previous exposure, antigen dose, infection 
rate, disease onset, and symptomatology. With a few exceptions, such studies have 
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not been performed in the field of PNI. Studies performed thus far, have focused 
mainly on infections of the upper espiratory tract and herpesvirus infections, These 
studies have shown that introversion [2, 3], psychosocial load [2-5], and emotional 
dysfunction [5-8] are related to the manifestation f these infections. 
Ethical constraints, particularly inhumans, limit the possibility of studying experi- 
mentally induced infections. This constraint can be circumvented byusing nonpatho- 
genic antigenic stimuli, such as those applied in vaccinations. An indication of the 
functioning of the integrated system isgiven by antibody levels thus evoked or cellular 
responses as measured by the proliferative capacity of the lymphocytes. Only a few 
human studies have been performed using this paradigm. After the vaccination of 
students with trivalent influenza vaccine, Bovbjerg et al. [9] demonstrated a negative 
relationship between distress and the level of proliferative r sponse of blood lympho- 
cytes to the influenza virus in vitro. Locke et al. [10] used a trivalent influenza vaccine 
as well, but failed to find any associations between antibody levels after immunization 
and psychological variables uch as life stress, depression, anxiety, and helplessness. 
Antibody formation after hepatitis Bvaccination has been measured insome previ- 
ous studies on stress-induced immunomodulation. Contrary to expectations, Petty 
et al. [11] reported apositive correlation between peak antibody titers and negatively 
perceived stressful events, irascibility, depression, and anxiety during the induction 
phase of immunization. Glaser et al. [12] vaccinated students on the first of a 3-day 
examination period. Seroconversion after the first vaccination was found to be nega- 
tively related to anxiety and self-reported stressfulness of life situations. We have 
previously reported that hepatitis B vaccination i  subjects participating in a study 
on the immunogenicity of low-dose rDNA hepatitis Bvaccine has yielded correspond- 
ing data [13]. Chronic psychological stress reported early in the study (month 2) 
was inversely related to antibody levels 7 months after immunization. Although 
associations were in the same direction for stress scores measured at month 6, these 
failed to reach statistical significance. These findings led us to hypothesize that psycho- 
logical variables influence antibody formation mainly during the induction phase of 
the immune response, when memory cells are generated. This may explain why the 
booster vaccination 6 months after priming results in lower antibody levels. 
Our previous tudy contained two rather unique elements. First, we applied mea- 
sures of self-reported chronic psychological stress as evaluated from questionnaires, 
instead of groups of subjects exposed to specific stressful life episodes such as academic 
exams, divorce, or the death of a loved one. Second, the dose of the vaccine adminis- 
tered to the volunteers was considerably lower than those usually applied in regular 
vaccination programs. In rodents, suboptimal dosing of antigen is recommended 
for the detection of stress effects on immune reactivity [14]. The present study was 
undertaken to determine whether the previously observed inverse relation between 
HBs-antibody levels and reported psychological stress is maintained, now applying 
the vaccine dose administered regularly in vaccination programs. To optimize the 
experimental conditions, the study was performed using a group of students who 
scored extremely low or high on a combination ofstress questionnaires. It was hypothe- 
sized that, as in the previous tudy, HBs antibody levels of highly stressed individuals 
are lower than those of subjects coring low on the stress questionnaires, specially 
during the induction phase of immunization. 
Psychological stress and anti-HBs levels 
Table I . -Group  means for the EPCL and HSCL at selection 
(month 0) 
Number  of  
EPCL*  HSCL* subjects 
Low/ low 16.0 ( _+ 4.9) 64.2 (2.7) 19 
Low/h igh 27.1 (9.4) 91.4 (13.5) 18 
High/ low 78.3 (27.3) 76.7 (6.4) 15 
High/h igh 97.9 (38.0) 113.4 (15.9) 16 
Groups:  low/low: low score on EPCL  and low score on HSCL;  
low/high: low score on EPCL  and high score on HSCL;  h igh/  
low: high score on EPCL  and low score on HSCL;  h igh/high:  high 
score on EPCL  and high score on HSCL.  
*Values expressed as mean(s), standard deviation(s) in paren- 
theses. 
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METHOD 
Subjects 
Sixty-eight students (43 women and 25 men with a mean age of 21.8 _+ 3.0 years) volunteered for the 
vaccination study, They were selected from a population of 390 Utrecht University students of different 
curricula in their second and third year, all of whom had completed the selection questionnaires. The 
questionnaires included measures of daily problems, symptoms, and biographical data. To maximize 
the chance of finding effects of  psychological variables, subjects coring extremely low or high on the 
psychological questionnaires were asked to participate in the vaccination study. Potential participants had 
to meet one of the following four criteria: a low or high score on both selection tools (Everyday Problem 
Checklist [EPCL] [15] and the Hopkins Symptom Checklist [HSCL] [16]); a low score on the EPCL but 
a high score on the HSCL; or a high score on the EPCL combined with a low score on the HSCL. 
Because the EPCL and the HSCL are correlated (r= 0.59-0.62) selection criteria for the low/low groups 
and high/high groups were more extreme (10o70 lowest and highest) than for the low/high and high/low 
groups (30% lowest and highest). Group means for the EPCL and HSCL at selection (month 0) are shown 
in Table 1. Subjects were informed on the vaccination and blood drawing procedures and asked whether 
they were prepared to complete the questionnaires once more. Before entering the study, informed consent 
was obtained from all participants. 
Subjects were checked for abnormalities in health status or medicinal drug use. This led to the removal 
of one subject suffering from psoriasis. There were equal numbers of males and females among the 
four groups. 
Psychological measures 
The following questionnaires were used in the study: 
• The Everyday Problem Checklist (EPCL) [15, 17], measured the frequency and intensity of chronic 
and everyday stressors during the 2 months prior to questionnaire completion. The EPCL is a Dutch 
114-item checklist with proven validity and reliability containing items from the following domains: 
(1) family life; (2) living conditions; (3) working conditions; (4) physical appearance and own perfor- 
mance; (5) transactions and business; (6) social life; and (7) confrontations. 
• The Hopkins Symptom Checklist (HSCL) [16, 18], assessed psychoneurotic and psychosomatic symp- 
toms during the week preceding questionnaire completion; 
• A questionnaire assessed health and biographical data including gender, age, alcohol use, smoking 
habits, body weight, and height. 
Questionnaires were filled out twice: as a selection instrument before entering the study and 6 months 
after the first vaccination. They were encoded, completed anonymously, and returned by mail. 
Factor analyses on the EPCL and HSCL resulted in one principal component, suggesting one underlying 
concept. Following Cohen et al. [19], two stress index scores combining the two questionnaires were 
calculated, representing the degree of psychological stress experienced by the subjects at the beginning 
and at the end of the study: 
1. A stress index score-month-0 (SI-0): Using the EPCL and HSCL sum scores of month 0, a single 
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principal component was obtained accounting for 79°7o f the variance. Both questionnaires loaded 
0.89 on this factor. 
2. A stress index score-month-6 (SI-6): Using the EPCL and HSCL completed at month 6, a single 
principal component was obtained accounting for 81 07o of the variance. The questionnaires loaded 
0.90 on this factor. 
These stress index scores (i.e., factor scores based on principal components analyses) were used in the 
statistical nalyses. 
Using body weight and height measures, Quetelet indices were calculated for each participant, indicating 
over- or underweight s atus. 
Vaccination 
A recombinant DNA hepatitis B vaccine (HB-VAX-DNA; Merck Sharp & Dohme) was administered 
intramuscularly in the triceps muscle. The standard immunization protocol was applied, including vaccina- 
tions of a dose of 10 micrograms at months 0, 1, and 6. All vaccines used in the study were from one 
single batch. 
Antibody levels 
Antibody levels to hepatitis B surface antigen (anti-HBs) were determined with a direct noncompetitive 
"sandwich" assay based on an enzyme-linked immunosorbent assay (ABAU-STD-SET, Sorin Biomedica, 
Saluggia, Italy). Plasma samples were incubated overnight at room temperature in wells coated with 
HBsAg. After washing the wells, an enzyme tracer, consisting of HBsAg conjugated to horseradish 
peroxidase, was added and incubated for 4 hours at room temperature. Enzyme activity was measured 
by adding a chromogen/substrate dilution of tetramethylbenzidine, 0.005070 H202, and citrate buffer. 
Results were read with a spectrophotometer at 450 nm after adding sulfuric acid as a blocking reagent. 
Antibodies were determined four times during the vaccination program: at months 0, 2, 6, and 7, and 
quantified using the WHO standard preparation [20]. All assays were read in a blind coded manner. At 
time 0, anti-HBs levels from all participants were negative. Only subjects with a detectable antibody level 
(/>1 IU/I) after vaccination were included in statistical nalyses. 
Statistical analyses 
Because anti-HBs titers were not distributed normally, data were log-transformed. Although an extreme 
group design was used, the changes in scores on EPCL and HSCL over time prevented us from applying 
analysis of variance. Instead, hierarchical multiple regression analyses were performed to assess which 
variables influence antibody levels. Groups of variables were entered stepwise inthe equation. Once (groups 
of) variables were entered, they remained in the regression equation. To reduce variance and enhance the 
sensitivity of the design, for the analyses on antibody concentrations of months 6 and 7, the antibody 
levels of the preceding assessment (anti-HBs-2 and anti-HBs-6, respectively) were entered instep 1. Lifestyle 
variables, such as smoking and alcohol consumption are known to influence antibody concentrations 
following vaccination [21]. Body mass is expected to influence uptake of the vaccine and therefore the 
resulting antibody level [21]. Gender is known to affect antibody formation in vivo, with women having 
higher antibody levels than men [21]. To control for these variables, the number of cigarettes smoked 
daily, weekly alcohol consumption, Quetelet index, and gender (0 = male, 1 = female) were entered in step 
2. In the last step, the psychological stress measures (SI-0 and S1-6) were entered independently. In step 
3a, SI-0 was entered. In step 3b, SI-6 was entered instead of SI-0. With the F-test for model comparison 
it was calculated whether the stepwise addition of new variables in the equation resulted in a significant 
increase in the explained variance (AR2). For every step the cumulative R2 is given and AR 2 for every 
additional step. To be able to compare the relative importance of these factors, standardized partial 
regression coefficients (13) are presented. 
To calculate the required sample size we assumed that R 2= 0.50. A value of R 2= 0.50 was decided on 
for two reasons: (1) Stevens i  of the opinion that this is a reasonable estimate for social science research 
[22]; and (2) anti-HBs titers of the different months were expected to correlate highly and would, as such, 
explain a large proportion of the variance. According to Stevens [22], given a power of I] = 0.80, and a 
significance l vel of ct = 0.05, six predictors, and R 2 = 0.50, at least 70 subjects are required for a meaningful 
regression equation. 
RESULTS 
Tables  II and  I I I  summar ize  the means ,  s tandard  dev iat ions ,  and  in tercor re la t ions  
o f  the var iab les  under  s tudy.  Tab le  IV shows the results o f  the regress ion  analyses.  
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Table I I I .-Number of responders (anti-HBs >/1 
IU/1) and geometric means (GM) with 95070 
confidence interval (95% CI) of anti-HBs levels 
in 68 healthy volunteers 
Number of GM (95% CI) 
responders responders 
Month 2 60 22 (16-30) 
Month 6 67 66 (50-87) 
Month 7 66 1905 (1318-2754) 
Anti-HBs concentrations of  the preceding assessment were entered in the first step 
in the regression analyses of  the antibody levels of  months 6 and 7. Ant ibody levels 
determined at month 2 were found to be highly predictive, accounting for 54% of 
the variance in antibody concentrations at month 6 (see Table IV). Anti-HBs levels 
at month 6 were less predictive and accounted for 27°70 of the variance in antibody 
concentrations at month 7. Furthermore, gender-related differences were observed 
in anti-HBs levels at month 6, indicating higher antibody levels for women. In addition, 
a negative relationship between smoking and anti-HBs levels at month 6 was found. 
Ant ibody formations 2 and 7 months after the first vaccination were not significantly 
influenced by smoking, alcohol consumption, Quetelet index, or gender. In the last 
step, the SI scores were entered. Regression analyses did not reveal a relationship 
between stress index score SI-0 and antibody levels at month 2, 6, or 7 after having 
controlled for the variables entered in steps 1 and 2. Subsequently, SI-6 instead of 
SI-0 was entered in the statistical analyses of  antibody levels at months 6 and 7, and 
failed to add significantly to the explained variance of  any dependent measure as well 
(see Table IV). 
Table IV . -  Results of stepwise regression analyses of anti-HBs levels (IU/1) after vaccination 
Anti-HBs month 2 Anti-HBs month 6 Anti-HBS month 7 
[3 R 2 AR-' [3 R-" AR 2 [3 R" &R 2 
Step 1 
Anti-HBs-2 - - 0.73*** 0.54*** - - 
Anti-HBs-6 . . . .  0.52*** 0.27*** 
Step 2 
Gender 0.01 ~ 0.24"**-~ 0.06 
Quetelet 0.25"~ -0.08 ~^ "'*** 0.12"** 0.08 l0  34*** 
Smoking 0.11 ~0.07 -0  18"* [u .oo 0.16 ' 
Alcohol -0.02 J 0103 J 0.18 
0.08 
Step 3a 
SI-0 -0.09 0.08 0.01 0.03 0.66*** 0.00 -0.11 0.35*** 0.01 
Step 3b 
SI-6 - - 0.02 0.66*** 0.00 0.08 0.35*** 0.01 
Gender: 0 = male; 1 = female. 
*p < 0.10; **p < 0.05; ***p < 0.01. 
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Sample size 
The nonsignificant associations found may be due to the sample size being too small. 
A priori, the sample size required for a reliable regression equation was calculated 
assuming that R:= 0.50 (see Method section: Statistical Analyses). Given the results 
presented in Table IV, we assessed the minimal number of subjects required to get 
a significant increment in proportion of explained variance by SI-0 and SI-6 [23]. For 
the equation with anti-HBs titers at month 2 and month 7 as the dependent variables, 
358 and 259 subjects would be required, respectively. No sample size was calculated 
for the equation with antibody levels at month 6, given the minimal increase in 
explained variance by SI-0 and SI-6. However, the question arises whether an increase 
in sample size to get a statistically significant effect is relevant, given the low 13 and 
AR 2 values, indicating the absence of any clinically relevant effect. 
DISCUSSION 
The present study was undertaken to evaluate the role of the antigen dose in the 
previously reported relationship between psychological stress and early antibody re- 
sponse in human volunteers following hepatitis B vaccination [ 13]. It is well established 
that, after the primary administration of antigen, antibodies develop slowly. De- 
pending on the antigen dose, antibody titers usually are low or even nondetectable 
after one vaccination. Due to memory cell formation, re-exposure to the vaccine at 
a later stage results in a considerable increase in specific antibodies. The anamnestic 
antibody response reflects the outcome of a complicated series of cellular events 
triggered by the primary vaccination. Based on the results of our previous tudy [13] 
we generated the hypothesis that psychological stress influences, in particular, the 
initial phase of the immune response. It was envisaged that the degree of stress- 
mediated immunomodulation in this early stage of immune reactivity could be depen- 
dent on antigen dose. In the present study, using the normal and thus higher dose of 
vaccine, no significant effects of (chronic) psychological stress on anti-HBs antibody 
levels could be demonstrated. 
It has been reported by Moynihan et al. [14] that mice, exposed to a single stress 
session (electric footshock) 24 hours after immunization with a protein antigen, show 
a reduced anamnestic antibody response compared to nonstressed animals. This result 
was obtained using low, suboptimal concentrations of the antigen in priming the 
mice, as well as in the booster injection. Interestingly enough, the suppression of the 
secondary antibody response was no longer demonstrable using a fivefold higher 
antigen dose to elicit the anamnestic response. Due to practical constraints we could 
not include, in the present study, a sample of subjects who received a suboptimal 
dose of HBs vaccine in the primary vaccination, and were subsequently boostered 
with the optimal dose of antigen. Therefore, it remains an open question whether 
the antigen dose-dependent stress-related suppression of the anamnestic HBs antibody 
response in the human model predominantly reflects a stress-mediated modulation 
of the induction phase of the immune response. However, based on these results, it 
is tempting to conclude that under certain conditions tress-induced immunomodula- 
tion, in this case antibody formation after vaccination, is influenced by antigen dose. 
Until now, studies on the psychological influences on antibody formation after 
hepatitis B vaccination have not allowed straightforward conclusions, because results 
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have been overly inconsistent. A recent study [24] showed that disclosure of traumatic 
experiences in four consecutive writing sessions, prior to vaccination, influences anti- 
body formation i  a positive way. Three other studies have also focused on psychologi- 
cal stress. Two of these used the same vaccine and vaccination protocol [11, 12], 
whereas in the third study some slight modifications had been implemented [13]. The 
results obtained ranged from negative to positive and nonsignificant correlations 
between anti-HBs levels and psychological stress measures. The inconsistency in results 
might at least partly be explained by the fact that in human studies the definition and 
quantification of psychological stress is complicated. In a recent meta-analysis of the 
literature on stress and immunity in humans, Herbert and Cohen [25] conclude that 
objective stressful events are related to larger immune changes than subjectave self- 
reports of stress. When using questionnaires, it is often difficult o control for poten- 
tially confounding variables, such as the willingness to reveal stressful events, emo- 
tional expression, or defensive coping styles, which have been reported to influence 
both the way questionnaires are completed and immunity [26, 27]. In addition, psycho- 
logical variables might exert different influences in the various tages of the immuniza- 
tion process, which in the case of hepatitis Bvaccination takes everal months. Related 
to this is the problem that distress levels or other psychological variables might fluctuate 
during this period. These are not necessarily measured by the questionnaires u ed or 
linked to the stressor the subject is supposed to be exposed to. 
The paradigm used in this study differs from the one generally employed in human 
PNI research. In most studies, in vitro immune parameters are assessed as measures 
for in vivo immune functioning. It is hypothesized that the neural and endocrine 
system have exerted their influence on the immune cells prior to blood drawing and 
in an indirect way are reflected in in vitro assays. However, the intricate interplay 
between the involved systems (neural, endocrine, and immune) during an immunologi- 
cal reaction is intrinsically neglected. The level of antibodies reflects the outcome 
of many steps in the immune response from the initial processing of antigens by 
antigen-presenting cells to the final production of immunoglobulins by activated B
cells. The actions of the integrated system are reflected in the total functioning of the 
immune system. 
We consider the vaccination model as a useful one in human PNI research, but 
recommend some modifications in future studies. In light of our previous results, the 
present findings lead us to the suggestion of administering vaccines in suboptimal 
doses. Furthermore, to diminish the influence of unexpected stressful situations as 
much as possible, vaccines hould be administered with a shorter immunization 
regimen. 
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